Get started
Author

Pranay Dey

Targeting stem cells in the realm of drug-resistant breast cancer
2019 · Pranay Dey, Maitreyi Rathod, et al. · Breast Cancer Targets and Therapy · 64
PDF
Autophagy-mediated ID1 turnover dictates chemo-resistant fate in ovarian cancer stem cells
2024 · Pratham Phadte, Aniketh Bishnu, et al. · Journal of Experimental & Clinical Cancer Research · 18
Recent advancements in targeted protein knockdown technologies—emerging paradigms for targeted therapy
2023 · Mansi Joshi, Pranay Dey, et al. · Exploration of Targeted Anti-tumor Therapy · 14
PDF
Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer
2022 · Pranay Dey, Mansi Joshi, et al. · Cellular Oncology · 13
Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer
2023 · Pranay Dey, Nikhil Gadewal, et al. · International Journal of Biological Macromolecules · 5
In Silico Identification of Potential Phosphorylation in the Cytoplasmic Domain of Epithelial Cell Adhesion Molecule
2020 · Arijit Mal, Pranay Dey, et al. · ACS Omega · 4
Hotspot mutations in HER2 interfaces destabilize structure, causing breast cancer treatment failure
2025 · Pranay Dey, Aniketh Bishnu, et al. · Oncogene · 3
PDF
Expanding the Scope of HER2-targeted Medicine Neratinib to Combat Triple- Negative Breast Cancer by Inhibiting the EGFR-ERK-STAT3 Signaling Axis
2026 · Mansi Joshi, Shalini Dimri-Wagh, et al. · Research Square
Breaking the Rhythm: Harnessing the Menstrual Cycle for Better Chemotherapy
2025 · Pranay Dey, Cathrin Brisken · Cancer Research
Works count: 13
Citation count: 121
H-index: 5
I10-index: 4
Year
Topic
Type